Correction: Evaluation of ERK as a therapeutic target in acute myelogenous leukemia

Leukemia
Ellen WeisbergJames D Griffin

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Related Papers

Nature Communications
Nicholas G ZaorskyVernon M Chinchilli
Nature Human Behaviour
Elliot C Brown, Soyoung Q Park
Nature Reviews. Disease Primers
Annamaria ColaoRosario Pivonello
© 2021 Meta ULC. All rights reserved